Home/Filings/4/0001627223-22-000039
4//SEC Filing

Shelton David C 4

Accession 0001627223-22-000039

CIK 0001627223other

Filed

May 8, 8:00 PM ET

Accepted

May 9, 5:42 PM ET

Size

14.7 KB

Accession

0001627223-22-000039

Insider Transaction Report

Form 4
Period: 2022-05-05
Shelton David C
GC, Corp. Secretary & SVP
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-05-0567,73633,868 total
    Exercise: $14.43Exp: 2030-03-02Common Stock (67,736 underlying)
  • Exercise/Conversion

    Common Stock

    2022-05-05$5.40/sh+83,044$448,438134,169.116 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-05-0583,0440 total
    Exercise: $5.40Exp: 2026-03-01Common Stock (83,044 underlying)
  • Sale

    Common Stock

    2022-05-05$39.99/sh83,044$3,320,93051,125.116 total
  • Sale

    Common Stock

    2022-05-05$39.99/sh67,736$2,708,76351,125.116 total
  • Exercise/Conversion

    Common Stock

    2022-05-05$14.43/sh+67,736$977,430118,861.116 total
Holdings
  • Common Stock

    (indirect: By GRAT)
    91,992
Footnotes (4)
  • [F1]Includes directly owned shares, restricted stock units, and dividend equivalent units.
  • [F2]Shares were sold in multiple transactions at prices ranging from $39.68 to $40.47.
  • [F3]Option award was granted on March 1, 2016 with vesting in three equal annual installments beginning March 1, 2017.
  • [F4]Option award was granted on March 2, 2020 with vesting in three equal annual installments beginning March 2, 2021.

Issuer

Chemours Co

CIK 0001627223

Entity typeother

Related Parties

1
  • filerCIK 0001645179

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 5:42 PM ET
Size
14.7 KB